1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key benefits to the stakeholder
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Process
3. EXECUTIVE SUMMARY
3.1. Key Findings
3.2. Analyst View
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View
5. GLOBAL ORGAN TRANSPLANT MARKET BY PRODUCT TYPE
5.1. Introduction
5.2. Organ preservation solutions
5.2.1. Market opportunities and trends
5.2.2. Growth prospects
5.2.3. Geographic lucrativeness
5.3. Transplant diagnostics
5.3.1. Market opportunities and trends
5.3.2. Growth prospects
5.3.3. Geographic lucrativeness
5.4. Tissue products
5.4.1. Market opportunities and trends
5.4.2. Growth prospects
5.4.3. Geographic lucrativeness
5.5. Others
5.5.1. Market opportunities and trends
5.5.2. Growth prospects
5.5.3. Geographic lucrativeness
6. GLOBAL ORGAN TRANSPLANT MARKET BY ORGAN TYPE
6.1. Introduction
6.2. Heart
6.2.1. Market opportunities and trends
6.2.2. Growth prospects
6.2.3. Geographic lucrativeness
6.3. Intestine
6.3.1. Market opportunities and trends
6.3.2. Growth prospects
6.3.3. Geographic lucrativeness
6.4. Kidney
6.4.1. Market opportunities and trends
6.4.2. Growth prospects
6.4.3. Geographic lucrativeness
6.5. Liver
6.5.1. Market opportunities and trends
6.5.2. Growth prospects
6.5.3. Geographic lucrativeness
6.6. Lung
6.6.1. Market opportunities and trends
6.6.2. Growth prospects
6.6.3. Geographic lucrativeness
6.7. Pancreas
6.7.1. Market opportunities and trends
6.7.2. Growth prospects
6.7.3. Geographic lucrativeness
7. GLOBAL ORGAN TRANSPLANT MARKET BY END-USERS
7.1. Introduction
7.2. Hospitals
7.2.1. Market opportunities and trends
7.2.2. Growth prospects
7.2.3. Geographic lucrativeness
7.3. Transplant Centers
7.3.1. Market opportunities and trends
7.3.2. Growth prospects
7.3.3. Geographic lucrativeness
7.4. Others
7.4.1. Market opportunities and trends
7.4.2. Growth prospects
7.4.3. Geographic lucrativeness
8. GLOBAL ORGAN TRANSPLANT MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. By Product Type
8.2.2. By Organ Type
8.2.3. By End-users
8.2.4. By Country
8.2.4.1. United States
8.2.4.1.1. Market Trends and Opportunities
8.2.4.1.2. Growth Prospects
8.2.4.2. Canada
8.2.4.2.1. Market Trends and Opportunities
8.2.4.2.2. Growth Prospects
8.2.4.3. Mexico
8.2.4.3.1. Market Trends and Opportunities
8.2.4.3.2. Growth Prospects
8.3. South America
8.3.1. By Product Type
8.3.2. By Organ Type
8.3.3. By End-users
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.1.1. Market Trends and Opportunities
8.3.4.1.2. Growth Prospects
8.3.4.2. Argentina
8.3.4.2.1. Market Trends and Opportunities
8.3.4.2.2. Growth Prospects
8.3.4.3. Others
8.3.4.3.1. Market Trends and Opportunities
8.3.4.3.2. Growth Prospects
8.4. Europe
8.4.1. By Product Type
8.4.2. By Organ Type
8.4.3. By End-users
8.4.4. By Country
8.4.4.1. Germany
8.4.4.1.1. Market Trends and Opportunities
8.4.4.1.2. Growth Prospects
8.4.4.2. France
8.4.4.2.1. Market Trends and Opportunities
8.4.4.2.2. Growth Prospects
8.4.4.3. UK
8.4.4.3.1. Market Trends and Opportunities
8.4.4.3.2. Growth Prospects
8.4.4.4. Italy
8.4.4.4.1. Market Trends and Opportunities
8.4.4.4.2. Growth Prospects
8.4.4.5. Others
8.4.4.5.1. Market Trends and Opportunities
8.4.4.5.2. Growth Prospects
8.5. Middle East and Africa
8.5.1. By Product Type
8.5.2. By Organ Type
8.5.3. By End-users
8.5.4. By Country
8.5.4.1. Saudi Arabia
8.5.4.1.1. Market Trends and Opportunities
8.5.4.1.2. Growth Prospects
8.5.4.2. Israel
8.5.4.2.1. Market Trends and Opportunities
8.5.4.2.2. Growth Prospects
8.5.4.3. Others
8.5.4.3.1. Market Trends and Opportunities
8.5.4.3.2. Growth Prospects
8.6. Asia Pacific
8.6.1. By Product Type
8.6.2. By Organ Type
8.6.3. By End-users
8.6.4. By Country
8.6.4.1. China
8.6.4.1.1. Market Trends and Opportunities
8.6.4.1.2. Growth Prospects
8.6.4.2. Japan
8.6.4.2.1. Market Trends and Opportunities
8.6.4.2.2. Growth Prospects
8.6.4.3. India
8.6.4.3.1. Market Trends and Opportunities
8.6.4.3.2. Growth Prospects
8.6.4.4. South Korea
8.6.4.4.1. Market Trends and Opportunities
8.6.4.4.2. Growth Prospects
8.6.4.5. Indonesia
8.6.4.5.1. Market Trends and Opportunities
8.6.4.5.2. Growth Prospects
8.6.4.6. Taiwan
8.6.4.6.1. Market Trends and Opportunities
8.6.4.6.2. Growth Prospects
8.6.4.7. Thailand
8.6.4.7.1. Market Trends and Opportunities
8.6.4.7.2. Growth Prospects
8.6.4.8. Others
8.6.4.8.1. Market Trends and Opportunities
8.6.4.8.2. Growth Prospects
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisition, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. OrganOx Limited
10.2. GlaxoSmithKline Plc.
10.3. Pfizer
10.4. XVIVO Perfusion AB (Organ Assist B.V.)
10.5. Paragonix Technologies Inc.
10.6. Novartis AG
10.7. Preservation Solution Inc.
10.8. Water Medical System LLC
10.9. Sanofi S.A
10.10. Bridge to Life Ltd.